The intelligence layer for China’s R&D pipeline

China Science Briefing

Chinese institutions publish thousands of research papers and policy signals daily, but most global media captures only a fraction. China Science Briefing addresses this asymmetry by monitoring hundreds of Chinese academic journals, government sources, and research institutions, then distilling what matters into a single, curated read.

The product operates across three cadences — daily, weekly, and monthly — each calibrated to a different user. Daily editions track breaking research and policy announcements. Weekly digests offer a consolidated view of the most significant developments. Monthly briefings provide strategic-level analysis for executives and investors who need the landscape, not the noise.

Coverage spans biotech, AI, energy, and materials science — priority sectors that receive sustained Chinese state investment. Subscribers also get context on government funding announcements and science policy shifts, which often precede major industrial moves.

The real value lies in reducing the cognitive load of monitoring China’s fragmented research ecosystem. For analysts tracking Chinese AI labs, venture investors mapping biotech pipelines, or policy researchers monitoring clean energy targets, the Briefing replaces hours of manual scanning with structured synthesis.

It also reveals something about China’s S&T system itself: the scale of state-linked research output now demands dedicated curation. The Briefing is a tool for navigating abundance, not scarcity — a sign of how deeply China’s innovation infrastructure has embedded itself into global R&D supply chains.

Three editions. One source. For anyone who needs to know what China is building next.

Why it matters:
As China accelerates R&D spending and patent output, the cost of missing a policy signal or breakthrough grows. The Briefing offers a structured entry point into that flow — a procurement tool for intelligence, not a summary feed.

View Product →